series-b
Stage
1
Investors
About
Pliant Therapeutics is a clinical-stage biotechnology company developing integrin-inhibiting therapies targeting fibrotic diseases and fibrotic tissue-specific integrins.
Explore Pliant Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.